Neuberger Berman Group LLC Amneal Pharmaceuticals, Inc. Transaction History

Neuberger Berman Group LLC

$123 Billion
Q3 2024

A detailed history of Neuberger Berman Group LLC transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Neuberger Berman Group LLC holds 3,787,665 shares of AMRX stock, worth $29.5 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

3,787,665

Previous 3,568,353 6.15%

Holding current value

$29.5 Million

Previous $22.7 Million 39.07%

% of portfolio

0.03%

Previous 0.02%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$6.42 - $8.83 $1.41 Million - $1.94 Million	219,312 Added 6.15%	3,787,665 $31.5 Million
Q2 2024 Nov 14, 2024	SELL	$5.36 - $7.11 $1.89 Million - $2.51 Million	-352,622 Reduced 8.99%	3,568,353 $22.7 Million
Q2 2024 Aug 13, 2024	SELL	$5.36 - $7.11 $1.89 Million - $2.51 Million	-352,622 Reduced 8.99%	3,568,353 $22.7 Million
Q1 2024 Nov 14, 2024	BUY	$5.24 - $6.34 $943,032 - $1.14 Million	179,968 Added 4.81%	3,920,975 $23.8 Million
Q1 2024 May 13, 2024	BUY	$5.24 - $6.34 $20.5 Million - $24.9 Million	3,920,975 New	3,920,975 $23.8 Million
Q4 2023 Nov 14, 2024	BUY	$3.36 - $6.21 $580,117 - $1.07 Million	172,654 Added 4.84%	3,741,007 $22.7 Million
Q4 2023 Feb 09, 2024	SELL	$3.36 - $6.21 $284,266 - $525,384	-84,603 Reduced 2.21%	3,741,007 $22.7 Million
Q3 2023 Nov 14, 2023	BUY	$2.76 - $4.59 $214,371 - $356,509	77,671 Added 2.07%	3,825,610 $16.1 Million
Q2 2023 Aug 11, 2023	BUY	$1.33 - $3.1 $86,864 - $202,467	65,312 Added 1.77%	3,747,939 $11.6 Million
Q1 2023 May 12, 2023	BUY	$1.27 - $2.7 $245,074 - $521,024	192,972 Added 5.53%	3,682,627 $5.12 Million
Q4 2022 Feb 13, 2023	BUY	$1.96 - $2.61 $3,402 - $4,530	1,736 Added 0.05%	3,489,655 $6.94 Million
Q3 2022 Nov 15, 2022	BUY	$2.02 - $3.62 $525,254 - $941,297	260,027 Added 8.06%	3,487,919 $7.06 Million
Q2 2022 Aug 15, 2022	BUY	$3.01 - $4.46 $88,867 - $131,677	29,524 Added 0.92%	3,227,892 $10.3 Million
Q1 2022 May 13, 2022	SELL	$3.9 - $4.89 $273,702 - $343,180	-70,180 Reduced 2.15%	3,198,368 $13.3 Million
Q4 2021 Feb 11, 2022	SELL	$3.95 - $5.85 $172,322 - $255,212	-43,626 Reduced 1.32%	3,268,548 $15.6 Million
Q3 2021 Nov 12, 2021	SELL	$4.31 - $5.64 $232,339 - $304,035	-53,907 Reduced 1.6%	3,312,174 $17.5 Million
Q2 2021 Aug 13, 2021	SELL	$5.12 - $6.82 $349,107 - $465,021	-68,185 Reduced 1.99%	3,366,081 $17.1 Million
Q1 2021 May 13, 2021	SELL	$4.74 - $7.38 $879,535 - $1.37 Million	-185,556 Reduced 5.13%	3,434,266 $23 Million
Q4 2020 Feb 10, 2021	SELL	$3.95 - $5.42 $259,337 - $355,850	-65,655 Reduced 1.78%	3,619,822 $16.5 Million
Q3 2020 Nov 12, 2020	SELL	$3.54 - $5.27 $190,122 - $283,035	-53,707 Reduced 1.44%	3,685,477 $14.3 Million
Q2 2020 Aug 13, 2020	SELL	$2.87 - $5.46 $260,888 - $496,324	-90,902 Reduced 2.37%	3,739,184 $17.8 Million
Q1 2020 May 14, 2020	BUY	$2.46 - $5.35 $767,938 - $1.67 Million	312,170 Added 8.87%	3,830,086 $13.3 Million
Q4 2019 Feb 12, 2020	SELL	$2.65 - $5.56 $130,599 - $274,013	-49,283 Reduced 1.38%	3,517,916 $16.9 Million
Q3 2019 Nov 13, 2019	BUY	$2.29 - $7.1 $2.25 Million - $6.98 Million	982,549 Added 38.01%	3,567,199 $10.4 Million
Q2 2019 Aug 13, 2019	BUY	$6.44 - $14.29 $5.63 Million - $12.5 Million	874,651 Added 51.15%	2,584,650 $18.5 Million
Q1 2019 May 13, 2019	BUY	$11.87 - $14.84 $341,226 - $426,605	28,747 Added 1.71%	1,709,999 $24.2 Million
Q4 2018 Feb 12, 2019	SELL	$13.09 - $21.49 $504,567 - $828,353	-38,546 Reduced 2.24%	1,681,252 $22.8 Million
Q3 2018 Nov 13, 2018	SELL	$16.4 - $24.27 $919,957 - $1.36 Million	-56,095 Reduced 3.16%	1,719,798 $38.2 Million
Q2 2018 Aug 13, 2018	BUY	$13.95 - $20.2 $24.8 Million - $35.9 Million	1,775,893 New	1,775,893 $29.1 Million

Others Institutions Holding AMRX

# of Institutions

184

Shares Held

141M

Call Options Held

57K

Put Options Held

49K

View Full List

About Amneal Pharmaceuticals, Inc.

Ticker AMRX
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 151,408,992
Market Cap $1.18B
Description
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...

More about AMRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Neuberger Berman Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Neuberger Berman Group LLC with notifications on news.

Account

Neuberger Berman Group LLC Amneal Pharmaceuticals, Inc. Transaction History